KRMD
KORU Medical·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 1
Bearish Engulfing
Ample Liquidity
High Gross Profit Margin
Revenue Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About KRMD
Koru Medical Systems, Inc.
A leading medical technology company that developing innovative and easy-to-use subcutaneous drug delivery systems
Healthcare Equipment and Supplies
--
10/17/2019
NASDAQ Stock Exchange
80
12-31
Common stock
100 Corporate Drive, Mahwah, New Jersey 07430
--
KORU Medical Systems, Inc., is a Delaware corporation. The company designs, manufactures and markets proprietary and innovative portable medical devices primarily for the outpatient infusion market that meets FDA quality and regulatory systems and international standards for quality system management. The company's development and marketing focus is primarily on its mechanical infusion products, the FREEDOM infusion system (which the company refers to as the "FREEDOM system" when used with one or more accessories), which includes the FREEDOM 60 syringe driver, the FreedomEdge syringe driver, the HIgH-Flo subcutaneous safety needle set and the RMS precision flow velocity tube.
Earnings Call
Q1/2025
Estimate EPS-0.03
Actual EPS0
Estimate Revenue8.86M
Actual Revenue9.60M
KORU Medical Systems' Q1 2025: Unpacking Contradictions in Tariff Effects, Product Launch Timelines, and Revenue Contributions
May 08,2025 07:33
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS-0.02
Actual EPS0.01
Estimate Revenue9.46M
Actual Revenue10.20M
Contradictions Unveiled: Analyzing U.S. Revenue, Market Share, and Product Development in 2025 Earnings Call
Aug 07,2025 04:03
Earnings Decrypt
Earnings Decrypt
Q3/2025
Estimate EPS-0.02
Actual EPS0
Estimate Revenue9.67M
Actual Revenue10.40M
KORU Medical's Q3 2025: Contradictions Emerge on International and U.S. Revenue Growth, Revenue Dynamics, and Margins
Nov 12,2025 09:07
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
KRMD has released its 2025 Q3 earnings. EPS was reported at 0, versus the expected -0.02, beating expectations. The chart below visualizes how KRMD has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
KRMD has released its 2025 Q3 earnings report, with revenue of 10.40M, reflecting a YoY change of 27.17%, and net profit of -777.97K, showing a YoY change of 50.79%. The Sankey diagram below clearly presents KRMD's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
